There was an unexpected surge in the diagnosis of Type 1 diabetes among children and teenagers worldwide amidst the global impact of the COVID-19 pandemic, according to a new study. The systematic review, published by the Journal of the American Medical Association (JAMA), analyzed 42 studies on diabetes incidence, including 17 studies involving nearly 38,000…

A recently published Canadian study has discovered the cellular process that allows vitamin K to protect against diabetes. The discovery opens up new ways to treat and prevent this growing epidemic that affects 415 million people worldwide. Vitamin K helps with gamma-carboxylation, one of the countless biochemical processes that our cells carry out, turning one substance…

There is “compelling epidemiological evidence” revealing a “strong association” between being obese or overweight and the risk of developing autoimmune diseases like Type 1 diabetes and multiple sclerosis. “From an immunological standpoint, the cellular and molecular mechanisms linked to this association include the overstimulation of T lymphocytes by nutrient- and energy-sensing pathways,” according to a…

Diabetes is a chronic, metabolic disease characterized by abnormally high blood sugar levels. High blood sugar levels can do serious damage to the eyes, kidneys, and other organs. This is why it is vital to seek treatment if you suspect you may have diabetes. It was estimated in 2019 that 37.3 million Americans—11.3 percent of…

Drugmaker Novo Nordisk has announced that it will significantly reduce insulin prices in the United States beginning next year—a relief for Americans struggling with high prices. Denmark-based Novo Nordisk will lower U.S. prices of several pre-filled insulin pens and vials by up to 75 percent for people living with Type 1 and Type 2 diabetes,…

The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical benefits scheme (PBS), sending its cost soaring for thousands of Australians. Fifteen thousand Australians, many whom are children, who rely on Novo Nordisk’s fast-acting insulin drug Fiasp to manage their Type 1 diabetes will now face skyrocketing…

A new modeling study has found that the number of young Americans who are likely to develop type 2 diabetes in the country could rise almost sevenfold over the next 40 years—an estimate that has shocked some experts. The study, “Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20…

Diabetes has become the third most life-threatening disease after cardiovascular disease and malignant tumors. According to the International Diabetes Federation, about 500 million people worldwide have diabetes mellitus and the number is increasing by 25,000 yearly, and those affected are found to be younger. A recent study shows that intermittent fasting can alleviate type 2…

The U.S. Food and Drug Administration (FDA) announced Thursday it approved a new drug that “can delay” the onset of stage 3 type 1 diabetes, which is the symptomatic stage of type 1 diabetes. The drug, teplizumab-mzwv, is to be used to delay the onset of stage 3 type 1 diabetes in adults and pediatric…

The Australian government has given a funding boost to an Australian biomedical research organisation, the Garvan Institute of Medical Research, to conduct clinical trials for the world’s first gene therapy for type 1 diabetes. The therapy was also developed thanks to the government’s ten-year $600 million (US$385 million) research accelerator program, targeted at addressing chronic and complex diseases….